Alzheimer's disease biomarker analysis using targeted mass spectrometry

Johan Gobom,Ann Brinkmalm,Gunnar Brinkmalm,Kaj Blennow,Henrik Zetterberg
DOI: https://doi.org/10.1016/j.mcpro.2024.100721
IF: 7.381
2024-01-23
Molecular & Cellular Proteomics
Abstract:Alzheimer's disease (AD) is characterised by several neuropathological changes, mainly extracellular amyloid aggregates (plaques), intraneuronal inclusions of phosphorylated tau (tangles), as well as neuronal and synaptic degeneration, accompanied by tissue reactions to these processes (astrocytosis and microglial activation) that precede neuronal network disturbances in the symptomatic phase of the disease. A number of biomarkers for these brain tissue changes have been developed, mainly using...
biochemical research methods
What problem does this paper attempt to address?